INBX

NASDAQStock

Inhibrx Biosciences, Inc.

$68.85-0.45 (-0.65%)

52-Week Range

$10.84
$93.51

Key Stats

Market Cap

1.0B

P/E Ratio

Dividend Yield

1.19%

Beta

1.51

Volume

101.9K

Avg Volume

176.1K

Performance

1M

-15.60%

3M

-9.07%

6M

+154.92%

YTD

-7.65%

1Y

+391.49%

3Y

+207.18%

5Y

+219.35%

Price Chart

ETF Exposure

INBX is held by 72 ETFs

ETFFund NameWeight
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About INBX ETF Exposure

Inhibrx Biosciences, Inc. (INBX) is held by 72 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.0B, INBX is a widely held institutional stock. The stock currently trades at $68.85 with a dividend yield of 1.19%. Investors can gain exposure to INBX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold INBX, sorted by portfolio weight.